Leadership Built by operators. For operators.
Priyanka
Founder & CEO
A graduate of Harvard University, Priyanka is a visionary entrepreneur and seasoned Clinical Operations Executive with over 18 years of experience across biotech, pharmaceutical, and medical device companies. After beginning her career with clinical training as a dentist, she transitioned to clinical operations, where she built a reputation for strategic leadership and high-velocity execution on complex global trials.
At industry leaders like Gilead Sciences, Abbott (St. Jude Medical), and Medtronic, she managed trials spanning 21+ countries with forecasting responsibility for study budgets up to $180M. She is known for radically accelerating clinical programs without compromising quality:
- Greenlit ~200 sites in under 4 months vs. a 10-month projection (>60% faster).
- Pulled First Patient In (FPI) forward by weeks and increased enrollment velocity by ~50%.
- Consistently prepared and delivered high-quality data for regulatory submissions.
Today, she leads Prana Clinical with a modern delivery model powered by AI-driven workflows and RBQM-first oversight, streamlining complexity and delivering outcomes with the transparent, ethical rigor that sponsors deserve.
To become the most trusted next-generation CRO—where AI-driven execution, global operational excellence, and uncompromising quality consistently deliver the fastest path from protocol to proof.
Our Values
Patients & Quality First
We move fast without compromising safety, scientific integrity, or inspection readiness. Speed and quality are not tradeoffs—they are both non-negotiable.
Own the Outcome
We take full accountability for startup velocity, enrollment execution, and clean, audit-ready delivery. No excuses, no surprises. When we commit, we deliver.
Speed Through Smart Systems
We use AI-driven workflows, RBQM-first oversight, and standardized playbooks to cut cycle time, reduce rework, and deliver predictable timelines. Systems scale; heroics don't.
Our Mission: Help sponsors bring life-changing treatments to patients sooner, with transparent execution, ethical rigor, and measurable outcomes.